New Rhein is a healthcare-focused venture capital firm that invests in specialty pharmaceutical and medical device companies. The firm typically participates in Seed, Series A, and Series B funding rounds, with a particular emphasis on Series A investments. New Rhein's partners leverage their extensive pharmaceutical industry experience, including operational and M&A expertise, to guide portfolio companies.
The firm's investment strategy aims to help management teams develop their businesses into attractive prospects for strategic investors. Notable portfolio companies include American Injectables, Corsair Pharma, and Neuraptive Therapeutics. New Rhein's partners utilize their industry knowledge and relationships to assist portfolio companies in achieving their growth objectives, focusing on creating value that appeals to potential strategic buyers in the healthcare sector.
New Rhein - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
